BIO Convention June 2015 Philadelphia

BELGIUM@BIO,PHILADELPHIA, USA

BELGIAN PAVILION, BOOTH 1413WWW.BELGIUMATBIOUS.BE

JUNE 15-18, 2015

BELGIUM@BIO USJUNE 15-18, 2015 3

INTRODUCTION 4

EXHIBITORS AT BIO 2015 PHILADELPHIA 5

ORGANIZERS BELGIAN PAVILION 36

PARTNERS BELGIAN PAVILION 40

TRADE & INVESTMENT OFFICES 43

\ TABLE OF CONTENTS

BELGIUM@BIO USJUNE 15-18, 20154

\ INTRODUCTION

Innovation is at the core of the life sciences sector and Belgium has a track record of developing ingenious ways to improve the quality of life of millions of people worldwide.

Not only extensive life sciences facilities support this high-level technology industry but also financial benefits for R&D companies, international collaborations that guarantee regular cash flow, world known educational systems, a promising product pipeline, and Belgium’s unique central location in Europe.

Belgium concentrates on a small territory (30,528 km2) more than 300 life sciences companies with biotech activities. In total, the life sciences sector employs more than 30,000 people (low bound estimation that does not take into account indirect employment generated by the sector). The majority of the companies is related to healthcare, but Belgium also has a strong representation of agricultural and industrial biotech companies.

The growing life sciences sector gathers 8 main Belgian universities, 19 research parks and 23 incubators, research institutes, academic hospitals, and clinical research organizations. Biotech companies have access to more than 500,000 square feet of highly flexible infrastructure.

Additional assets of Belgium includes: a supportive regulatory and political environment, a highly qualified and productive workforce, a competitive tax environment especially for research companies, a prominent location and an excellent logistical and business infrastructure.


page

ALTIUS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6APITOPE INTERNATIONAL . . . . . . . . . . . . . . . . 6ARGEN-X . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7ARLENDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7ASCLEPIA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8ATOMS & ART . . . . . . . . . . . . . . . . . . . . . . . . . . . 8B&C GROUP . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9BETA-CELL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9BIOCARTIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10BIOLOG EUROPE . . . . . . . . . . . . . . . . . . . . . . . 10BIOMEDICAL SYSTEMS. . . . . . . . . . . . . . . . . . . . 11BIO-SOURCING . . . . . . . . . . . . . . . . . . . . . . . . . 11BIOTECHSUBSIDY . . . . . . . . . . . . . . . . . . . . . . . .12BONE THERAPEUTICS . . . . . . . . . . . . . . . . . . . .12CAMEL-IDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13CELYAD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13CENTRE FOR DRUG DESIGN AND DISCOVERY .14CMAST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14CURAVAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15DE CLERCQ & PARTNERS . . . . . . . . . . . . . . . . .15DELPHI GENETICS . . . . . . . . . . . . . . . . . . . . . . .16EUROGENTEC . . . . . . . . . . . . . . . . . . . . . . . . . .16FLUIDDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17GALAPAGOS . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17GROUP-IPS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18GSK VACCINES . . . . . . . . . . . . . . . . . . . . . . . . . .18IMMUNXPERTS . . . . . . . . . . . . . . . . . . . . . . . . . .19INNOTUNE . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19I-TECH INCUBATOR . . . . . . . . . . . . . . . . . . . . . 20JANSSEN PHARMACEUTICA . . . . . . . . . . . . . . 20

page

JUNEAU CAYENNE . . . . . . . . . . . . . . . . . . . . . . .21KU LEUVEN RESEARCH & DEVELOPMENT . . .21MASTHERCELL . . . . . . . . . . . . . . . . . . . . . . . . . 22MULTIPLICOM . . . . . . . . . . . . . . . . . . . . . . . . . . 22MYCARTIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23NAUTADUTILH . . . . . . . . . . . . . . . . . . . . . . . . . 23NOVADIP BIOSCIENCES . . . . . . . . . . . . . . . . . . 24NOVOSANIS . . . . . . . . . . . . . . . . . . . . . . . . . . . 24ONTOFORCE . . . . . . . . . . . . . . . . . . . . . . . . . . 25OUAT! . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25OVIZIO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26PRODIGEST . . . . . . . . . . . . . . . . . . . . . . . . . . . 26PROGRESS PHARMA . . . . . . . . . . . . . . . . . . . . 27PROMETHERA BIOSCIENCES . . . . . . . . . . . . . 27QUASYS CONSULT . . . . . . . . . . . . . . . . . . . . . . 28ROUSSELOT . . . . . . . . . . . . . . . . . . . . . . . . . . . 28SYNOLYNE PHARMA . . . . . . . . . . . . . . . . . . . . 29TECH LANE GHENT SCIENCE PARK . . . . . . . . 29THERASOLVE . . . . . . . . . . . . . . . . . . . . . . . . . . 30TIGENIX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30TOXIKON EUROPE . . . . . . . . . . . . . . . . . . . . . . .31TRINEAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31UCB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32UGENT TECHTRANSFER . . . . . . . . . . . . . . . . . 32ULB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33UNIVERCELLS . . . . . . . . . . . . . . . . . . . . . . . . . . 33UNIVERSITÉ CATHOLIQUE DE LOUVAIN (UCL) 34VIB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34WBC INCUBATOR . . . . . . . . . . . . . . . . . . . . . . . 35

\ EXHIBITORS AT BIO 2015, PHILADELPHIA


Havenlaan 86 C BE-1000 BRUSSELS T +32 2 426 14 14 [email protected] www.altius.com

Contact: Christophe RONSE

Agoralaan A-bis BE-3590 DIEPENBEEK T +32 11 28 69 00 [email protected] www.apitope.com

Contact: Hayley FRENCH

ALTIUS is one of the largest indepen-dent law firms in Belgium. We assist biotech companies in their international and Belgian transactions, and represent them in IP and regulatory litigation.

Apitope is focused on the discovery and development of disease modifying peptide immunotherapies for the treat-ment of autoimmune diseases.

\ ALTIUS

\ APITOPE INTERNATIONAL


1 avenue de l’Hôpital, building B34 BE-4000 LIÈGE T +32 4 366 43 97 [email protected] www.arlenda.com

Contact: Benoît VERJANS

Arlenda is a CRO specialized in statistics for research, clinical development, CMC and supply chain.

Technologiepark 30 BE-9052 GHENT T +32 9 243 40 70 [email protected] www.argen-x.com

Contact: Debbie ALLEN

arGEN-X is a clinical-stage biopharma-ceutical company focused on creating and developing differentiated thera-peutic antibodies for the treatment of cancer and severe autoimmune diseases.

\ ARLENDA

\ ARGEN-X


Damvalleistraat 49 BE-9070 DESTELBERGEN T +32 468 13 70 14 [email protected] www.asclepia.com

Contact: Frederik DEROOSE

Grote Markt 12/3 BE-3200 AARSCHOT T +32 494 57 81 22 [email protected] www.atomsandart.com

Contacts: Robert DEKKER Leen LIMBOURG

Asclepia offers since 2009 medicinal chemistry oriented research and ser-vices from early hits to IND stage by designing and delivering innovative, therapeutically relevant, drug-like com-pounds.

Atoms & art provides development support for companies and due di-ligence/ad-hoc management for in-vestors. A passionate team for efficient, customized solutions inspired by cre-ative thinking.

\ ASCLEPIA

\ ATOMS & ART


Laarbeeklaan 103 BE-1090 JETTE T +32 2 477 43 49 [email protected] www.beta-cell.com

Contact: Kris MOTMANS

Beta-Cell develops cell-based products and services for diabetes management. The company’s lead product, Beta-GRAFT®, is an encapsulated porcine beta cell graft for the treatment of diabetes.

Rue Granbonpré 11 BE-1435 MONT-SAINT-GUIBERT T +32 10 23 88 53 (David Fontaine) T +1 610 898 38 73 (Michael Duda) [email protected] [email protected] www.bnc-group.com

Contacts: David FONTAINE Michael DUDA

B&C Group is a global expert in Clinical Trial Services. Clinical trial Supply/IMP services: - Sourcing - Packaging & Labelling - QP release - Warehousing and distribution

Biomedical Samples services:- Design and assembly of sample collection kits

- Biomedical Sample logistics- Biomedical Sample storage- Centralized Biomedical Sample Management

\ BETA-CELL

\ B&C GROUP


Generaal de Wittelaan 11 B3 BE-2800 MECHELEN T +32 15 63 26 00 [email protected] www.biocartis.com

Contact: Kristoff BAETEN

Liege Airport - Building 52 BE-4460 GRACE-HOLLOGNE T +32 4 225 50 64 [email protected] www.biologeurope.com

Contact: Nicolas COGNEAU

Biocartis aims to improve quality of life by enabling direct access to per-sonalized medicine for patients.

BioLog Europe is a Life Sciences Supply Chain Association based in Belgium, in the heart of the European Biopharma valley. We support projects and ex-pansions plans of companies willing to grow in EU.

\ BIOCARTIS

\ BIOLOG EUROPE


Avenue Hippocrate 5 BE-4000 LIÈGE T +32 497 48 51 22 [email protected] www.bio-sourcing.com

Contact: Bertrand MEROT

Bio-Sourcing aims to harness nature’s power to produce large quantities of specific proteins in milk in order to increase the availability of drugs for animal health.

Chaussée de Wavre 1945 BE-1160 BRUSSELS T +32 2 661 20 70 [email protected] www.biomedsys.com

Contact: Erik FALVEY

Biomedical Systems is a premier global provider of centralized diagnostic ser-vices. Our solutions include cardiac safety, pulmonary function, imaging and electronic clinical Outcome Assess-ments (eCOA).

\ BIO-SOURCING

\ BIOMEDICAL SYSTEMS


Nieuwe Dreef 2 A BE-9880 AALTER T +32 493 49 66 62 [email protected] www.biotechsubsidy.com

Contact: Marc VAN de CRAEN

Rue Auguste Piccard 37 BE-6041 GOSSELIES T +32 2 529 59 90 [email protected] www.bonetherapeutics.com

Contact: Enrico BASTIANELLI

Support for European (e.g. H2020) and National (e.g. IWT, MRC, innovative UK) grant applications focusing on biotech projects. We operate from Belgium and UK.

Advanced bone regenerative company with a unique approach to develop autologous and allogeneic cell therapy products for fracture repair and frac-ture prevention.

\ BIOTECHSUBSIDY

\ BONE THERAPEUTICS


Rue Edouard Belin 12 BE-1435 MONT-SAINT-GUIBERT T +32 10 39 41 00 [email protected] www.celyad.com

Contact: Georges RAWADI

Celyad (fak Cardio3 BioSciences) is a leader in engineered cell therapy with clinical programs targeting indications in cardiology and oncology. Founded in 2007 and based in the Walloon region of Belgium, Celyad leverages research collaborations in the USA and in Europe with the Mayo Clinic (MN, USA), and Dartmouth College (NH, USA).

Rue Vandenboogaerde 25 BE-1080 BRUSSELS T +32 473 45 45 93 [email protected] www.camel-ids.com

Contact: Ludwig CAMUSOT

Personalized radioimmunotherapies (RIT) to treat oncology patients lever-aging recombinant, small antigen-binding fragments derived from camelid heavy-chain-only antibodies coupled with radioisotope.

\ CELYAD

\ CAMEL-IDS


Gaston Geenslaan 2 BE-3001 LEUVEN T +32 16 85 26 05 [email protected] www.CD3.eu

Contact: Patrick CHALTIN

Georges Van Dammeplein 57 BE-9140 TEMSE T +32 498 10 65 35 [email protected] www.cmast.be

Contact: Glenn VAN DAEL

The Centre for Drug Design and Discovery (CD3) focuses on the dis-covery of new and innovative small molecule drugs in collaboration with academic research groups or small (spin-off) companies.

CMAST provides Consultancy, Project Management & Supporting Technology Services in the domain of Supply Chain, Life Sciences and Strategic Colla-borations.

\ CENTRE FOR DRUG DESIGN AND DISCOVERY

\ CMAST


Edgard Gevaertdreef 10a BE-9830 SINT-MARTENS-LATEM T +32 9 280 23 40 [email protected] www.dcp-ip.com

Contact: Ann DE CLERCQ

De Clercq & Partners is an IP service firm focusing on life sciences including biotechnology, medical devices, diagnostics, medicinal chemistry, bio-informatics, agricultural & veterinary sciences.

Avenue de Villefranche 57 BE-1330 RIXENSART T +32 2 686 04 45 [email protected] www.curavac.com

Contact: Stéphane HUBERTY

CuraVac is developing therapeutic vac-cines for autoimmune diseases.

\ DE CLERCQ & PARTNERS

\ CURAVAC


Rue Bois Saint-Jean 5 BE-4102 SERAING T +32 4 372 74 00 [email protected] www.eurogentec.com

Contact: Pascal BOLON

Eurogentec is an ISO 9001, ISO 13485, cGMP and FDA accredited custom manufacturer of products and services for the Life Science Research, Molecular Diagnostic and Biopharmaceutical the-rapeutic markets.

Rue A. de Saint-Exupery 5 BE-6041 GOSSELIES T +32 71 25 10 00 [email protected] www.delphigenetics.com

Contact: David de PERMENTIER

Technologies for DNA and protein productions (including antibodies) by using unique expertise in plasmid stabilization systems. Licenses and services based on its technologies and expertise.

\ EUROGENTEC

\ DELPHI GENETICS


Groeningenlei 132 BE-2550 KONTICH T +32 3 450 87 20 [email protected] www.fluidda.com

Contact: Debbie DEFOSSE

FLUIDDA is the world leader in the field of Functional Respiratory Imaging (FRI) research and development.

Generaal de Wittelaan L11 A3 BE-2800 MECHELEN T +32 15 34 29 00 [email protected] www.glpg.com

Contact: Elisabeth GOODWIN

Galapagos (Euronext: GLPG; OTC: GLPYY) is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.

\ FLUIDDA

\ GALAPAGOS


Avenue Robert Schuman 42 BE-1400 NIVELLES 7905 Browning Road, Suite 214 Pennsauken, NJ 08109, USA T +1 (856) 857 4124 [email protected] www.group-ips.com

Contact: Grégory MISONNE

Multidisciplinary engineering company operating internationally and having more than 22 years of experience in 650 industrial projects worldwide.

Rue de l’Institut 89 BE-1330 RIXENSART T +32 10 85 85 00 [email protected] www.gsk.com

Contact: Philippe DENOEL

GSK is a world’s leading vaccine com-pany, involved in vaccine innovation, research, development and production.

Please contact us [email protected]

\ GROUP-IPS

\ GSK VACCINES


Voorhoutkaai 20 BE-9000 GENT T +32 9 224 40 82 [email protected] www.innotune.com

Contact: Lieven DE SMEDT

InnoTune invests and co-leads early stage BioTech Venture & Alliances to sustainable International Business, sa: BioFilm-based AST, GT-HT microfluidic screening (BioMillenia), AH recombinant Vaccines.

Rue Auguste Piccard 48 BE-6041 GOSSELIES T +32 71 96 01 33 [email protected] www.immunxperts.com

Contact: Mayuko Oh WONG

ImmunXperts is team of experts in the immunogenicity field that can provide risk assessments and risk management services from drug discovery stages all the way until clinical development.

\ INNOTUNE

\ IMMUNXPERTS


Turnhoutseweg 30 BE-2340 BEERSE T +32 14 60 21 11 [email protected] www.janssenpharmaceutica.be

Contact: Frederik WITTOCK

Janssen Pharmaceutica NV is a global center for integrated R & D, production and distribution of medicines. The company has several sites in Belgium, employs about 4500 people and is active in a wide range of therapeutic areas including neurosciences, oncology and infectious diseases.

Rue Auguste Picard 48 BE-6041 GOSSELIES T +32 71 91 99 50 [email protected] www.i-tech-incubator.be

Contact: Marie BOUILLEZ

i-Tech Incubator is an incubation structure for young, innovative com-panies. It offers housing and services supporting business planning, incor-poration, financing and development of companies active in domains as biotech, medical device, engineering and clean technology,...i-Tech Incubator finally also opens its networks of specialists in very diverse competence fields for its clients (legal, financial, scientific).

\ JANSSEN PHARMACEUTICA

\ I-TECH INCUBATOR


Steenweg op Antwerpen 99 b2 BE-2300 TURNHOUT T +32 14 80 04 40 [email protected] www.juneaucayennehealthcare.com

Contact: Nicole VERBEECK

Full-service communication agency for healthcare, life science and technology communication.

Waaistraat 6 - B 5105 BE-3000 LEUVEN T +32 16 85 26 05 [email protected] www.kuleuven.be/lrd

Contact: Patrick CHALTIN

KU Leuven Research & Development (LRD) is the TTO of the University of Leuven (KU Leuven) and is dedicated to transferring knowledge and technologies of KU Leuven to the marketplace.

\ JUNEAU CAYENNE

\ KU LEUVEN RESEARCH & DEVELOPMENT

Multiplicom


Galileïlaan 18 BE-2845 NIEL T +32 3 289 14 00 [email protected] www.multiplicom.com

Contact: Luc SEGERS

The leading Belgian biotech company that develops, manufactures and com-mercializes molecular diagnostic assays, provided as kits, which enable person-alized medicine.

Rue Auguste Piccard 48 BE-6041 GOSSELIES T +32 489 84 62 29 [email protected] www.masthercell.com

Contact: Thibault JONCKHEERE

MaSTherCell is a Contract Develop-ment and Manufacturing Organization (CDMO) on a mission to deliver optimized process industrialization capacities to CELL THERAPY organizations.

\ MULTIPLICOM

\ MASTHERCELL


Technologiepark 4 BE-9052 ZWIJNAARDE T +32 9 241 11 40 [email protected] www.mycartis.net

Contact: Paul LADESTEIN

MyCartis aims to enable clinical re-searchers to accelerate biomarker testing with an unprecedented level of biomarker information very quickly, accurately and cost-effectively.

\ MYCARTIS

Chaussée de la Hulpe 120 BE-1000 BRUSSELS T +32 2 566 80 00 [email protected] www.nautadutilh.com/en/home/expertises/industries/life-sciences/

Contact: Jo VANWITTENBERGH

We provide transactional, advisory & litigation legal services to biotech companies. From universities, spin-offs and startups to mature organisations and from professional associations to investors.

\ NAUTADUTILH


Bijkhoevelaan 32c BE-2110 WIJNEGEM T +32 3 485 50 16 [email protected] www.novosanis.com

Contact: Vanessa VANKERCKHOVEN

Novosanis designs and develops medical devices for a variety of applications, ranging from injection appliances to in vitro diagnostic accessories.

Novosanis has two medical devices in its portfolio. VAX-ID, a platform of pre-filled intradermal injection devices and Colli-Pee, a device for standardized collection of first void urine allowing detection of STIs and cancer biomarkers.

Chemin du cyclotron 6 BE-1348 LOUVAIN LA NEUVE T +32 10 77 92 20 [email protected] www.novadip.com

Contact: Jean-François POLLET

Novadip Biosciences develops innova-tive tissue engineering solutions based on stem cells from fatty tissue. Their lead product CREOST® provide new treatments for severe bone healing disorders.

\ NOVOSANIS

\ NOVADIP BIOSCIENCES


Ghelamco Business Center - 3rd floor Ottergemsesteenweg-Zuid 808 BE-9000 GENT T +32 4 268 21 82 [email protected] www.ontoforce.com

Contact: Peter VERRYKT

Ontoforce is a leading Belgian company that creates and implements linked data technology. Ontoforce is backed up by renowned institutes and industries like Harvard, MIT, UCSD and Gartner.

\ ONTOFORCE

Rue d’Alost 7 BE-1000 BRUXELLES T +32 487 15 16 69 [email protected] www.ouat.eu

Contact: Bart BROSIUS

OUAT! is on a mission to support technology innovation with its Bio-technology and Marketing expertise. You spend time on Your Innovation and we take care of Your Marketing.

\ OUAT!


Rue du Bourdon 100 BE-1180 UCCLE T +32 2 600 50 90 [email protected] www.ovizio.com

Contact: Philip MATHUIS

OVIZIO’s quantitative imaging devices provide real-time data to identify, assess and analyze cells based on a label-free « holographic » fingerprint and are used in bio-processing and diagnostics.

Technologiepark 3 BE-9052 GENT T +32 9 241 11 90 [email protected] www.prodigest.eu

Contact: Sam POSSEMIERS

ProDigest provides customized solu-tions related to gastrointestinal re-search to the operators in the market of functional food/feed and pharma-ceutical industry using the SHIME® technology platform.

\ OVIZIO

\ PRODIGEST


Watson & Crick Hill Rue Granbonpre 11 BE-1435 MONT-SAINT-GUIBERT T +32 10 39 43 00 [email protected] www.promethera.com

Contact: Frank HAZEVOETS

Promethera® Biosciences is a Belgian biopharmaceutical company, whose mission is to develop and commercialize cell therapy products to treat liver diseases.

Oude Baan 34 BE-2350 VOSSELAAR T +32 14 76 23 21 [email protected] www.progresspharma.eu

Contact: Dirk REYN

Progress Pharma is team of 8 seasoned executives that build companies around specific assets. They provide needed managerial skills and seed money together with an extensive investor and BD network to work together with founders, universities or small teams to advance assets.

\ PROMETHERA BIOSCIENCES

\ PROGRESS PHARMA


Meulestedekaai 81 BE-9000 GENT T +32 9 255 18 55 [email protected] www.rousselot.com

Contact: Jos OLIJVE

Rousselot is the leader in the production of high quality gelatins for food, pharmaceutical and medical applications. We offer gelatins low in endotoxin and controlled microbiology.

Boulevard Frère Orban 35 A BE-4000 LIÈGE T +32 4 254 55 88 [email protected] www.quasysconsult.com

Contact: Françoise SCHLEMMER

Quasys Consult is a Medical Devices consulting company. We help manu-facturers to penetrate the EU market and to be compliant with the EU legislation Services: EC REP, CE labelling, GMDN Code research,…

\ ROUSSELOT

\ QUASYS CONSULT


Volderstraat 1 BE-9000 GENT T +32 485 92 87 55 [email protected] www.techlaneghent.eu

Contact: Brecht LOOTENS

Tech Lane Ghent Science Park is the prime life sciences destination in Flanders. Home to the Ghent biotech cluster, we encourage collaboration, synergy and symbiosis, based on a campus environment.

Rue Haute Claire 4 BE-4040 HERSTAL T +32 4 228 80 40 [email protected] www.synolyne-pharma.com

Contact: Houtai CHOUMANE

Synolyne Pharma presents Vegetech insideTM, an breakthrough biomaterial platform based on animal-free ultrapure chitosan, for the design and development of safer and highly efficient therapeutic medical devices. We capitalize on our technologies to develop a pipeline of innovative products aimed at addressing the vast unmet medical needs in rheuma-tology, ophthalmology, hemostasis, bio- surgery, tissue engineering and regenerative medicine. We build strong and sustainable partnerships that benefit from on our expertise in design, development, manu-facturing and regulatory.

\ TECH LANE GHENT SCIENCE PARK

\ SYNOLYNE PHARMA


Agoralaan Building Abis BE-3590 DIEPENBEEK T +32 11 28 69 75 [email protected] www.therasolve.com

Contact: Joseph TSHIMBALANGA

TheraSolve NV is a Belgian medical technology company developing inno-vative, user-friendly, and cost-effective solutions promoting medication adher-ence.

Haasrode Researchpark 1724 Romeinse straat 12 - Bus 2 BE-3001 LEUVEN T +32 16 39 60 60 [email protected] www.tigenix.com

Contact: Claudia JIMENEZ

European cell therapy company with an advanced clinical stage pipeline of adult stem cell therapies for the treatment of inflammatory and auto-immune diseases and a commercial product (ChondroCelect).

\ THERASOLVE

\ TIGENIX


Dulle Grietlaan 17/3 BE-9050 GENTBRUGGE T +32 9 272 75 35 [email protected] www.trinean.com

Contact: Philippe STAS

Trinean is an instrumentation company bringing micro-volume molecular spec-troscopy to the next level by combining best in class analytical software with highly standardized read-out platforms.

Romeinsestraat 12 BE-3001 LEUVEN T +32 16 40 04 84 [email protected] www.toxikon.be

Contact: Kevin BREESCH

Toxikon is an international CRO with ISO, GMP and GLP accreditations, sup-porting pharma, biotech and medical device industries to deliver product development services from concept to final product.

\ TRINEAN

\ TOXIKON EUROPE


Allée de la Recherche 60 BE-1070 BRUXELLES T +32 2 559 99 99 [email protected] www.ucb.com

Contact: Emmanuel LACROIX

UCB, Brussels, is a global biopharma-ceutical company focused on the discovery and development of inno-vative medicines for several diseases of the immune system and central nervous system.

Bollebergen 2B BE-9052 GHENT T +32 9 264 78 83 [email protected] www.techtransfer.ugent.be

Contact: Piet DE VOS

UGent TechTransfer manages the IP of UGent, drives the use of that IP through the creation of spin-offs and licensing and supports the UGent research community in creating collaborations with industry.

\ UCB

\ UGENT TECHTRANSFER


Univercells is providing biomanufac-turing & process development exper-tise using cutting-edge technologies to decrease dramatically the cost of bio-logics.

Avenue F.D. Roosevelt 50 CP161 BE-1050 BRUSSELS T +32 2 650 45 71 [email protected] www.ulbtto.be

Contact: Arnaud QUINTENS

Rue Auguste Piccard 48 BE-6041 GOSSELIES T +32 2 318 83 48 [email protected] www.univercells.com

Contact: Benjamin DAMIEN

ULB is a major university located in the heart of Brussels (25,000 students, 500 research units, 35 spin-offs) and also relies upon a network of one academic hospital and 5 university hospitals.

\ UNIVERCELLS

\ ULB


VIB is an entrepreneurial institute in-volved in frontline life sciences research and its translation in products and eco-nomic activities.

1 place de l’Université (box L0-01-05) BE-1348 LOUVAIN-LA-NEUVE T +32 10 47 24 71 [email protected] www.ltto.com/en

Contact: Xavier LAMPE

LTTO is the technology transfer office of UCL, created to maximize the economic valorization of our research, in particular in life science, through out-licensing and by creating innovative spin-off.

Rijvisschestraat 120 BE-9052 GHENT T +32 9 244 66 11 [email protected] www.vib.be

Contact: Jérôme VAN BIERVLIET

\ VIB

\ UNIVERSITÉ CATHOLIQUE DE LOUVAIN (UCL)

IS A PROUD MEMBER OF THE FLANDERS WELCOME TEAM - LIFE SCIENCES


Avenue de l’hôpital 11 B-34 BE-4000 LIÈGE T +32 4 246 51 10 [email protected] www.wbc-incubator.be

Contact: Julie LAVALOU

WBC Incubator offers a panel of tools to help emerging life sciences compa-nies such as:- Access to a network of experts and experienced managers;

- Pre-financing capacity (pre and post creation).

\ WBC INCUBATOR


\ ORGANIZERS BELGIAN PAVILION

BIOWIN 37

BRUSSELS INVEST & EXPORT 37

FLANDERS INVESTMENT & TRADE 38

FLANDERSBIO 38

LIFETECH.BRUSSELS 39

WALLONIA EXPORT-INVESTMENT AGENCY (AWEX) 39


Brussels Invest & Export is the foreign trade and investment agency of the Brussels Capital Region. Our mission is to help Brussels-based companies find their way to international markets as well as acting as a one-stop shop to welcome foreign investors in Brussels, which is the ideal launching pad for their exports across Europe. A team of almost 90 economic and commercial attachés are posted abroad and provide free guidance to Brussels-based SME’s all over the world.

Point Centre Rue Georges Lemaître 19 BE-6041 GOSSELIES (CHARLEROI) T +32 71 37 63 86 [email protected] www.biowin.org

Avenue Louise 50 b4 BE-1050 BRUSSELS T +32 2 800 40 00 [email protected] www.brusselsinvestexport.be

Delegates: Ghislain BREYDEL (Project Manager sector Life Sciences), Gilles BREDAS (Trade Commissioner Montreal), Luc LIPPENS (Trade Commissioner New York)

BioWin is the regional reference player for all the stakeholders (companies, universities and research centers) involved in R&D or skills development projects in the fields of health biotechnology and medical technologies. The cluster gathers more than 500 members that form a unique ecosystem in various key technological areas such as cell therapy, biopharmaceuticals, im-munology, radiation applications in health-care, diagnostics, biotech products and medical equipment.

\ BRUSSELS INVEST & EXPORT

\ BIOWIN

YOUR GATEWAY TO BIOTECH AND MEDTECH EXCELLENCE IN WALLONIA (BELGIUM)


FlandersBio, the networking organization for the life sciences sector in Flanders, counts more than 280 members. Flanders-Bio supports and facilitates the sector’s sustained development to ensure that life sciences remains a strong driver for the economic growth in the region. By organ-izing networking activities we facilitate the transfer of knowledge between the different actors. FlandersBio assists you in finding your partner within the network of life sciences actors, e.g. expert centers, life sciences companies, Venture Capitalists, re-search organizations, subsidy agencies, etc.

Koning Albert II-laan 37 BE-1030 BRUSSELS T +32 2 504 87 11 [email protected] www.flandersinvestmentandtrade.com

Delegates: Marc VAN GASTEL, Jan WAUTERS, Mieke PYNNAERT

Jean-Baptiste de Ghellincklaan 13 bus 0102 BE-9051 GHENT T +32 9 241 80 41 [email protected] www.flandersbio.be

Delegates: Jonas DE BACKER, Henk JOOS, Willem DHOOGE

Flanders Investment & Trade is the gov-ernment agency supporting home-based companies doing business abroad and for-eign companies looking to set up or expand operations in Flanders, the northern region of Belgium.

\ FLANDERSBIO

\ FLANDERS INVESTMENT & TRADE




lifetech.brussels by impulse.brussels gath-ers around 100 innovative companies, hos-pitals and R&D labs. By supporting high- potential start-ups and identifying poten-tial synergies and encourage international partnerships, the cluster drives innovation in the Health sector. Moreover, the members can also rely on the services of impulse.brussels to support them in areas such as financing, public grants, European R&D Calls, environmental permits,…

Chaussée de Charleroi 110 BE-1060 BRUSSELS T +32 2 413 52 13 [email protected] www.lifetech.brussels.com

Delegate: Camille MOMMER

\ LIFETECH.BRUSSELS

Place Sainctelette 2 BE-1080 BRUSSELS T +32 2 421 82 11 [email protected] www.wallonia.be www.investinwallonia.be

The Wallonia Foreign Trade and Investment Agency is responsible for export promotion of Wallonia-based companies and foreign investment attraction in Wallonia, Belgium.

\ WALLONIA EXPORT-INVESTMENT AGENCY (AWEX)


\ PARTNERS BELGIAN PAVILION

BIO.BE 41

PHARMA.BE 41

WALLONIA REGION TECHNOLOGY DEVELOPMENT DEPARTMENT 42


Pharma.be is the Belgian Pharmaceutical Industry Association which represents 140 innovative (bio) pharmaceutical companies. Our mission is to promote a better human healthcare through therapeutic innovation. The association’s top priority is to give patients the earliest possible access to to-morrow’s research and development-driven medicines.

Boulevard Auguste Reyers 80 (Diamant Building) BE-1030 BRUSSELS T +32 2 238 98 44 www.bio.be

Chaussée de la Hulpe 166 BE-1170 BRUSSELS T +32 2 661 01 02 www.pharma.be

Bio.be is the Belgian biotechnology indus-try organization. Bio.be represents the companies and professionals involved in re-search, development, testing, production or marketing of biotechnology applications, as well as those servicing the biotechnology community.

\ PHARMA.BE

\ BIO.BE


Place de la Wallonie 1 BE-5100 NAMUR T +32 81 33 45 62 www.recherche-technologie.wallonie.be

Through its Technology Development Department, the Wallonia Region has designed a series of incentives to boost regional innovation and research and to meet the needs of all companies, from start-ups to well-established enterprises.

Wallonia’s R&D incentives include:- Grants for basic industrial research

(up to 80% R&D costs);- Recoverable advances for applied

research (up to 75% R&D costs);- Other opportunities include grants

for feasibility studies or intellectual property.

\ WALLONIA REGION TECHNOLOGY DEVELOPMENT DEPARTMENT


\ TRADE & INVESTMENT OFFICES

ATLANTA Djazia FILOSO (Wallonia) [email protected] Wim VAN CAUTEREN (Brussels & Flanders) [email protected]

BOSTON Maxime VAN CAUTER (Wallonia - Technology Attaché) [email protected]

CHICAGO Gilles Philippart de FOY (Wallonia) [email protected] Jean-Pierre VASAUNE (Wallonia - Investment) [email protected] Piet MORISSE (Flanders & Brussels) [email protected] Claude STOMP (Flanders - Investment) [email protected]

HOUSTON Yves DUBUS (Brussels & Wallonia) [email protected]

LOS ANGELES Eric GABRYS (Brussels) [email protected] Tonia VAN de VYVER (Flanders) [email protected] Wim SOHIER (Flanders - Technology Attaché) [email protected]

SAN FRANCISCO Baudouin de HEMPTINNE (Wallonia) [email protected]

NEW YORK Luc LIPPENS (Brussels) [email protected] Edith MAYEUX (Wallonia) [email protected] Benoit REINARDS (Flanders - Investment) [email protected] Luc STRYBOL (Flanders) [email protected] Jan WAUTERS (Flanders - Technology Attaché) [email protected]

WASHINGTON Bernard GEENEN (Brussels & Wallonia) [email protected]

BIO Convention June 2015 Philadelphia

Business

Transcript of BIO Convention June 2015 Philadelphia